Related Experiment Video
Updated: Jun 23, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation
Hanane Boukarabila1, Andrew J Saurin, Eric Batsché
1Centre d'Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée, Campus de Luminy, 13288 Marseille Cedex 09, France.
Fusion proteins PML/RARA and PLZF/RARA drive acute promyelocytic leukemia (APL). Unlike PML/RARA, PLZF/RARA repression persists after all-trans retinoic acid (ATRA) treatment due to sustained Polycomb repressive complex 1 (PRC1) recruitment.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- Acute promyelocytic leukemia (APL) involves oncogenic fusion proteins PML/RARA and PLZF/RARA.
- These proteins aberrantly recruit corepressors, repressing retinoic acid (RA) target genes and driving leukemogenesis.
- While PML/RARA-mediated repression is reversible with all-trans RA (ATRA), PLZF/RARA-mediated repression is ATRA-insensitive, a key difference in disease persistence.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying ATRA-insensitive repression by PLZF/RARA.
- To investigate the differential recruitment of Polycomb group (PcG) complexes by PML/RARA and PLZF/RARA.
- To determine the role of Bmi-1 and PRC1 in PLZF/RARA-driven leukemogenesis.
Main Methods:
- Chromatin immunoprecipitation assays to assess PcG complex recruitment.
- Co-immunoprecipitation to analyze protein-protein interactions.
- Assessment of cellular transformation and leukemic development in relevant models.
Main Results:
- Both PML/RARA and PLZF/RARA recruit Polycomb-repressive complex 2 (PRC2) to RA response elements.
- PLZF/RARA, but not PML/RARA, directly interacts with Bmi-1 and stably incorporates into the PRC1 complex.
- PLZF/RARA mediates ectopic recruitment of PRC1 to RA response elements, which persists after ATRA treatment, unlike PRC2.
- Bmi-1 is essential for PLZF/RARA's cellular transformation activity.
Conclusions:
- PLZF/RARA-mediated ATRA resistance is due to sustained recruitment of PRC1, mediated by Bmi-1.
- PRC1 plays a critical role in PLZF/RARA-driven myeloid leukemic development.
- Targeting PRC1 may offer therapeutic strategies for ATRA-resistant APL.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Induced Pluripotent Stem Cells
Somatic cells are...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Master Transcription Regulators
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

